AUDREY LANEY: Open Payments
NPI 1205271343 · ELIZABETHTON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$700 in 20 payments from 9 companies in 2025. Trend: 2023 $264 · 2024 $246 · 2025 $700
Food & beverage: $700
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $172 |
| AstraZeneca Pharmaceuticals LP | 7 | $142 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Alkermes, Inc. | 1 | $80 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Lilly USA, LLC | 2 | $43 |
| ABBVIE INC. | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Novo Nordisk Inc | 1 | $18 |
Products named: FANAPT, Auvelity, BREZTRI, LYBALVI, TRELEGY ELLIPTA, AIRSUPRA, MOUNJARO, QULIPTA.
Industry payments across TN — which companies pay providers there.
